In new research, investigators at Massachusetts General Hospital (MGH) show that the 100-year-old Bacillus Calmette-Guérin (BCG) vaccine, originally developed to prevent tuberculosis, protects ...

Vaccines can protect us well beyond their intended role in remarkable and often unexpected ways, says Lisa Jarvis for ...

The Bacillus Calmette-Guérin (BCG) vaccine - which prevents tuberculosis - offers multiple beneficial effects, and it's currently a recommended therapy for non–muscle-invasive bladder cancer. In a new ...

During the frightening early weeks of the COVID-19 pandemic in March of 2020, Kiehl Sundt, of Sequim, Washington, became one of the first people on Earth to receive an experimental dose of Moderna’s ...

Amid debate on the effectiveness of the tuberculosis vaccine, a new study suggests that the vaccine is protective against TB in children under 5, but adolescents and adults in high-burden countries ...

The Johns Hopkins Center for Immunization Research is looking for volunteers to participate in an outpatient BCG vaccine study. If you are a healthy adult between the ages of 18 and 65, you may be ...

Bacillus Calmette-Guérin (BCG) vaccines are given to more than 100 million children every year, but there is considerable debate regarding the effectiveness of BCG vaccination in preventing ...

BOSTON – Researchers at Massachusetts General Hospital (MGH), published a new paper in Cell Reports Medicine demonstrating the protective potential of multiple doses of the Bacillus Calmette-Guerin ...

Researchers headed by a team at Pitt University, in collaboration with scientists at Cornell University, have developed a self-destructing, intravenous (i.v.) Bacillus Calmette-Guérin (BCG) vaccine ...

The bacillus Calmette-Guérin (BCG) vaccine nearly halved the risk of progression among patients with non–muscle invasive bladder cancer (NMIBC) compared with transurethral resection of the bladder ...